Acquisition of the Kyra flow products from Telstra Health

• Acquisition of Kyra flow products strengthens Alcidion's patient flow solutions
• Expected to be earnings accretive from completion
• Upfront cash purchase price of $3.0M with potential earn-out of up to $1.0M

Alcidion Group Limited (ASX:ALC) has signed an Asset Sale Agreement to acquire the business and assets of Kyra Patient Flow Manager, Kyra Queue Manager, and Kyra IQ from Telstra Health. This acquisition aims to strengthen Alcidion's position as a leading provider of enterprise patient flow solutions across Australia, New Zealand, and the UK. The Kyra flow products, a proprietary suite of digital solutions addressing patient flow and data access challenges, will expand Alcidion's presence in Australia, particularly in Queensland and Victoria. The acquisition is expected to be earnings accretive from completion, with an upfront cash purchase price of $3.0M and an additional earn-out of up to $1.0M based on future recurring revenue thresholds. The transaction is anticipated to close by the end of June 2026.

FY26 forecast revenue of $3.7M, underlying EBITDA of approximately $1.1M

The acquisition is expected to be earnings accretive from completion, reflecting the Kyra flow products' attractive recurring revenue and margin profile.